British pharma giant Shire (SHP) is set to sell its oncology business to French peer Servier for $2.4bn (£1.68bn). For those expecting management to put the struggling neurology business up for sale, this development comes as something of a surprise. It has also potentially thrown a spanner in the works of Takeda’s budding takeover: oncology is one of the key divisions the Japanese group is interested in.
IC TIP:
Buy
at
3607p